geritrex corp

Private

—N/Ahttps://geritrex.com

Last Round

Buyout/LBO

Jul 31, 2015

Last Round Size

$13.8M

Est. Valuation

$13.8M

Total Funding Raised

$13.8M

Company Overview

geritrex corp has raised $13.8M. It was founded in 1978.

Manufacturer and distributor of generic over-the-counter (OTC) pharmaceuticals and personal care products.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

geritrex corp Comparables

Compare geritrex corp with similar companies based on industry and business-model similarity.

No comparables are published for geritrex corp. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

geritrex corp Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Buyout/LBO	Jul 31, 2015	Demo	Demo	Demo	Demo

Book a demo to see all funding rounds

For institutional investors. Book with your work email.

geritrex corp Filings

Explore SEC and related filing metadata, where available.

geritrex corp filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Firmographic Details

Headquarters—

Year Founded1978

Last FundingJul 31, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?